United States Pharmaceuticals

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Track

Over the past 90 days, Shuttle Pharmaceuticals Holdings Inc. recorded 11 insider trading transactions, all involving HRT Financial LP. These activities resulted in a net negative value of approximately $318,243. The stock has experienced a 72.9% decline over the last 90 days, with the next earnings report scheduled for August 2026.
Ticker: SHPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Shuttle Pharmaceuticals Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 14 Jul 2026
Value US$3,399,230.76 | Price 274.72 | Shares 53,732 (+25.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-14 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
53,732 +25.9%
274.72
US$3,399,231 		53,732 +25.9% 274.72 US$3,399,231
2026-07-15 2026-07-13 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
82,979 -4.5%
108.39
US$3,782,040 		82,979 -4.5% 108.39 US$3,782,040
2026-07-13 2026-07-10 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
492 -27.3%
202.10
US$4,272,741 		492 -27.3% 202.10 US$4,272,741
2026-07-13 2026-07-09 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +15.8%
3.38
US$100,000 		1,000 +15.8% 3.38 US$100,000
2026-07-09 2026-07-08 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
18,531 -26.2%
3.52
US$65,229 		18,531 -26.2% 3.52 US$65,229
2026-07-09 2026-07-07 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
10,580 -13.0%
3.33
US$35,231 		10,580 -13.0% 3.33 US$35,231
2026-07-07 2026-07-06 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
9,022 -10.0%
3.51
US$31,667 		9,022 -10.0% 3.51 US$31,667
2026-07-07 2026-07-02 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
7,851 +9.5%
3.54
US$27,793 		7,851 +9.5% 3.54 US$27,793
2026-07-02 2026-07-01 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
3,959 +5.0%
3.30
US$13,065 		3,959 +5.0% 3.30 US$13,065
2026-07-01 2026-06-30 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
6,755 +9.4%
3.23
US$21,819 		6,755 +9.4% 3.23 US$21,819
2026-07-01 2026-06-29 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
25,836 +56.2%
3.44
US$88,876 		25,836 +56.2% 3.44 US$88,876
2024-01-02 2023-12-13 S Sale
2.6
Brown Milton
Non-Executive Director
2,921 -0.3%
0.46
US$1,353 		2,921 -0.3% 0.46 US$1,353
2023-12-20 2023-12-13 S Sale
2.3
Jacobs Bette
Non-Executive Director
4,157 -13.3%
0.46
US$1,926 		4,157 -13.3% 0.46 US$1,926
2024-03-14 2022-12-29 S Sale
1.6
Senanayake Chris
Non-Executive Director
1,626 -36.8%
1.61
US$2,610 		1,626 -36.8% 1.61 US$2,610
2023-01-09 2022-12-29 S Sale
1.6
Richards Steven M
Non-Executive Director
995 -36.8%
1.61
US$1,597 		995 -36.8% 1.61 US$1,597
2023-01-04 2022-12-29 S Sale
2.6
Brown Milton
Non-Executive Director
995 -0.1%
1.61
US$1,597 		995 -0.1% 1.61 US$1,597
2023-01-04 2022-12-29 S Sale
1.6
Adkins William
995 -0.5%
1.61
US$1,597 		995 -0.5% 1.61 US$1,597
2023-01-03 2022-12-29 S Sale
2.3
Jacobs Bette
Non-Executive Director
4,366 -12.3%
1.61
US$7,007 		4,366 -12.3% 1.61 US$7,007
2023-01-03 2022-12-29 S Sale
1.6
Jung Mira

Chief Scientific Officer

Officer
328 -0.0%
1.61
US$526 		328 -0.0% 1.61 US$526
2023-01-03 2022-12-29 S Sale
1.6
Dritschilo Anatoly

CEO and Chairman

Executive Director Large shareholder
8,372 -0.8%
1.61
US$13,437 		8,372 -0.8% 1.61 US$13,437
2023-01-03 2022-12-29 S Sale
1.6
Rich Tyvin

Chief Medical Officer

Officer
1,414 -36.8%
1.61
US$2,269 		1,414 -36.8% 1.61 US$2,269
2022-12-30 2022-12-29 S Sale
1.6
Vander Hoek Michael

Chief Financial Officer

Officer
2,243 -36.8%
1.61
US$3,600 		2,243 -36.8% 1.61 US$3,600
2022-12-30 2022-12-29 S Sale
1.6
Dritschilo Peter

President and COO

Officer
3,820 -36.8%
1.61
US$6,131 		3,820 -36.8% 1.61 US$6,131
Explore more

More insider trading research around Shuttle Pharmaceuticals Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America